The Liver Health Initiative

September 21, 2022

The Liver Home, a new patient-centered liver disease care model, is being introduced by Yale Medicine, Yale New Haven Health System Digestive Health Service Line.

September 07, 2022

WHO and CDC have laid out some ambitious goals for the treatment of hepatitis C, and HCV co-discoverer and vaccine developer Micheal Houghton, PhD, offers some insights and commentary on whether he feels it is realistic to consider the eradication of this stubborn and subtle virus.

September 07, 2022

The Liver Health Initiative’s Thelma King Thiel, and HCV co-discoverer and vaccine developer Michael Houghton, PhD, are a “Dynamic Duo” that are working together to bring about an end to this virus.

September 06, 2022

Nobel Prize Laureate Michael Houghton, PhD, discusses the arduous journey to find the virus and a subsequent investigational vaccine designed to prevent hepatitis C (HCV).

April 20, 2017

Liver health education seems to be absent from the final draft of the National Academy of Science's Strategy for Eliminating Viral Hepatitis B & C.

February 28, 2017

Elimination of viral hepatitis depends on individuals actively participating in their own healthcare and management. They can only do this if they understand why and how to protect their miraculous, life-sustaining liver from harm. Education is the key to prevention.